These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
636 related articles for article (PubMed ID: 34748375)
1. COVID-19 Vaccine Boosters for All Adults: An Optimal U.S. Approach? Sarpatwari A; Pandya A; Hyle EP; Persad G Ann Intern Med; 2022 Feb; 175(2):280-282. PubMed ID: 34748375 [TBL] [Abstract][Full Text] [Related]
2. Access considerations for a COVID-19 vaccine for South Africa. Bangalee V; Suleman F S Afr Fam Pract (2004); 2020 Oct; 62(1):e1-e4. PubMed ID: 33179954 [TBL] [Abstract][Full Text] [Related]
3. COVID vaccine boosters: the most important questions. Callaway E Nature; 2021 Aug; 596(7871):178-180. PubMed ID: 34354274 [No Abstract] [Full Text] [Related]
4. SARS-CoV-2 vaccine boosters: The time to act is now. Petersen M; Schwab J; Havlir DV PLoS Med; 2021 Dec; 18(12):e1003882. PubMed ID: 34882675 [TBL] [Abstract][Full Text] [Related]
5. The COVID vaccine challenges that lie ahead. Nature; 2020 Nov; 587(7835):522. PubMed ID: 33235368 [No Abstract] [Full Text] [Related]
6. Audio Interview: A New Look at Covid-19 Vaccine Boosters. Rubin EJ; Baden LR; Morrissey S N Engl J Med; 2021 Oct; 385(17):e72. PubMed ID: 34670050 [No Abstract] [Full Text] [Related]
11. A patent waiver on COVID vaccines is right and fair. Nature; 2021 May; 593(7860):478. PubMed ID: 34035532 [No Abstract] [Full Text] [Related]
12. What scientists do and don't know about the Oxford-AstraZeneca COVID vaccine. Mallapaty S; Callaway E Nature; 2021 Apr; 592(7852):15-17. PubMed ID: 33762708 [No Abstract] [Full Text] [Related]
13. Consideration Of Value-Based Pricing For Treatments And Vaccines Is Important, Even In The COVID-19 Pandemic. Neumann PJ; Cohen JT; Kim DD; Ollendorf DA Health Aff (Millwood); 2021 Jan; 40(1):53-61. PubMed ID: 33211534 [TBL] [Abstract][Full Text] [Related]
14. In brief: Booster doses of mRNA-based COVID-19 vaccines for all adults. Med Lett Drugs Ther; 2021 Dec; 63(1640):201-202. PubMed ID: 35100238 [No Abstract] [Full Text] [Related]
15. COVID-19 Vaccine: Practical Clinical Considerations. Laine C; Cotton D; Moyer DV Ann Intern Med; 2021 May; 174(5):694. PubMed ID: 33769829 [TBL] [Abstract][Full Text] [Related]
16. COVID-19 boosters in rich nations will delay vaccines for all. Chagla Z; Pai M Nat Med; 2021 Oct; 27(10):1659-1660. PubMed ID: 34465921 [No Abstract] [Full Text] [Related]
18. Is ipsilateral administration of COVID-19 vaccine boosters the optimal approach? Iro MA; Buckland M EBioMedicine; 2023 Dec; 98():104852. PubMed ID: 38251467 [No Abstract] [Full Text] [Related]
19. COVID boosters are back: what scientists say about whether to get one. Lenharo M Nature; 2023 Sep; 621(7979):449-450. PubMed ID: 37704846 [No Abstract] [Full Text] [Related]
20. Association of Homologous and Heterologous Vaccine Boosters With COVID-19 Incidence and Severity in Singapore. Tan SHX; Pung R; Wang LF; Lye DC; Ong B; Cook AR; Tan KB JAMA; 2022 Mar; 327(12):1181-1182. PubMed ID: 35147657 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]